Hui Sian Tay1, Roy L Soiza2, Arduino A Mangoni3. 1. Department of Medicine for the Elderly, Ward 102, Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK. 2. Department of Medicine for the Elderly, Aberdeen Royal Infirmary, NHS Grampian, and Health Services Research Unit, University of Aberdeen, Aberdeen, UK. 3. School of Medicine, University Flinders, Adelaide, South Australia.
Abstract
INTRODUCTION: Anticholinergic drugs are associated with poor outcomes in older patients but no specific intervention strategies aimed at reducing anticholinergic drug exposure have been described. OBJECTIVES: To identify whether a consultant-led medication review targeting anticholinergics would reduce anticholinergic drug exposure [number of anticholinergic drugs and Anticholinergic Risk Scale (ARS) score]. METHODS: The first phase of the audit included 70 consecutive admissions (mean age 84 years, 53 women). ARS score was calculated on admission and after initial consultant review. Re-audit was undertaken on another 70 consecutive admissions (mean age 83 years, 43 women) after introducing a system of informing the responsible consultant of the ARS score at their first review. RESULTS: Drugs with anticholinergic effects (n = 53) were prescribed preadmission to 45/140 (32%) of patients. Consultant geriatrician review reduced ARS scores (p = 0.01), especially following the introduction of the information system (p = 0.002). In the first arm of the audit, 51 (73%) patients had ARS of 0 after a consultant's review compared with 47 (67%) patients on admission, whilst 67 (96%) patients had ARS of 2 or less after a consultant's review compared with 63 (90%) patients on admission. In the second arm of the audit, 59 (84%) patients had ARS of 0 after a consultant's review compared with 48 (69%) patients on admission, whilst 70 (100%) patients had ARS of 2 or less after a consultant's review compared with 69 (99%) patients on admission. Anticholinergic drugs were either stopped, or their dose reduced, in 35% of patients in the first arm of the audit and in 73% of patients in the re-audit (odds ratio 5.0, 95% confidence interval 1.4-17.8). CONCLUSION: Consultant-led medication review (standard practice) was effective at reducing anticholinergic drug exposure in the acute setting. A system of alerting clinicians to patients prescribed anticholinergic medications further reduced anticholinergic drug exposure.
INTRODUCTION: Anticholinergic drugs are associated with poor outcomes in older patients but no specific intervention strategies aimed at reducing anticholinergic drug exposure have been described. OBJECTIVES: To identify whether a consultant-led medication review targeting anticholinergics would reduce anticholinergic drug exposure [number of anticholinergic drugs and Anticholinergic Risk Scale (ARS) score]. METHODS: The first phase of the audit included 70 consecutive admissions (mean age 84 years, 53 women). ARS score was calculated on admission and after initial consultant review. Re-audit was undertaken on another 70 consecutive admissions (mean age 83 years, 43 women) after introducing a system of informing the responsible consultant of the ARS score at their first review. RESULTS: Drugs with anticholinergic effects (n = 53) were prescribed preadmission to 45/140 (32%) of patients. Consultant geriatrician review reduced ARS scores (p = 0.01), especially following the introduction of the information system (p = 0.002). In the first arm of the audit, 51 (73%) patients had ARS of 0 after a consultant's review compared with 47 (67%) patients on admission, whilst 67 (96%) patients had ARS of 2 or less after a consultant's review compared with 63 (90%) patients on admission. In the second arm of the audit, 59 (84%) patients had ARS of 0 after a consultant's review compared with 48 (69%) patients on admission, whilst 70 (100%) patients had ARS of 2 or less after a consultant's review compared with 69 (99%) patients on admission. Anticholinergic drugs were either stopped, or their dose reduced, in 35% of patients in the first arm of the audit and in 73% of patients in the re-audit (odds ratio 5.0, 95% confidence interval 1.4-17.8). CONCLUSION: Consultant-led medication review (standard practice) was effective at reducing anticholinergic drug exposure in the acute setting. A system of alerting clinicians to patients prescribed anticholinergic medications further reduced anticholinergic drug exposure.
Entities:
Keywords:
anticholinergic drugs; deprescribing; drug withdrawal; elderly; prescribing
Authors: Estelle Lowry; Richard J Woodman; Roy L Soiza; Sarah N Hilmer; Arduino A Mangoni Journal: J Clin Pharmacol Date: 2011-12-13 Impact factor: 3.126
Authors: Patrick Russell; Sara Laubscher; Gregory W Roberts; Arduino A Mangoni; Cameron McDonald; Ivanka Hendrix; Udul Hewage; Dirk Hofmann; Sophie Michell; Lauren Taeuber; Richard J Woodman; Sepehr Shakib; Gregory B Crawford; John Maddison; Campbell Thompson Journal: Ther Adv Drug Saf Date: 2019-06-04
Authors: Stéphane Sanchez; Jan Chrusciel; Biné Mariam Ndiongue; Caroline Blochet; Jean François Forget; Aude Letty; Paul Emile Hay; Jean Luc Novella Journal: Int J Environ Res Public Health Date: 2021-12-31 Impact factor: 3.390
Authors: Mohammed S Salahudeen; Adel Alfahmi; Anam Farooq; Mehnaz Akhtar; Sana Ajaz; Saud Alotaibi; Manal Faiz; Sheraz Ali Journal: J Clin Med Date: 2022-01-28 Impact factor: 4.241
Authors: Samuel R Neal; Adrian D Wood; Andrew D Ablett; Jenny S Gregory; Jordan Guillot; Helen M Macdonald; David M Reid; Phyo K Myint Journal: Ther Adv Drug Saf Date: 2020-05-27